Paroxysmal atrial fibrillation
The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
There has been a tendency to treat paroxysmal atrial fibrillation (PAF) in a similar way to sustained AF, but treatment objectives may be very different. We discuss current definitions, epidemiology, pathophysiology and natural history of PAF, and review evidence for its treatment and management. PAF comprises between 25% and 62% of cases of AF, with similar underlying causes to those in sustained AF. The main objective of management is prevention of paroxysms and long-term maintenance of sinus rhythm, and Class 1c drugs are highly effective, although beta-blockers are useful alternatives. If patients have severe coronary artery disease or poor ventricular function, amiodarone is probably the drug of choice. Although randomized controlled trials of thromboprophylaxis in patients with paroxysmal AF per se are lacking, the approach to patients with paroxysmal AF should be similar to that in patients with sustained AF, with warfarin for 'high risk' patients and aspirin for those at 'low risk'. Non-pharmacological therapeutic options, including pacemakers, electrophysiological techniques and the implantable atrial defibrillator, show great promise. Despite paroxysmal AF being a common condition, management strategies are limited by evidence from small randomized trials, with inconsistencies over the definition of the arrhythmia and the inclusion of only symptomatic subjects. Evidence for antithrombotic therapy is also based on epidemiological studies and subgroup analyses of the large randomized trials.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Andersen, H. R., Nielsen, J. C., Thomsen, P. E. B., Thuesen, L., Mortensen, P. T., Vesterlund, T., & Pedersen, A. K. (1997) · The Lancet · doi:10.1016/s0140-6736(97)03425-9 · Cited by 841 · cited 1×
“More importantly, further follow-up analysis showed an additive reduction in mortality and heart failure, with a slow progression to complete atrioventricular block in the absence of pre-existing conduction abnormalities.(81) Other trials such as the Canadian Trial of Physiological Pacing (CTOPP) are comparing VVIR pa…”
BackgroundPage, R. L., Wilkinson, W. E., Clair, W. K., McCarthy, E. A., & Pritchett, E. L. (1994) · Circulation · doi:10.1161/01.cir.89.1.224 · Cited by 627 · cited 2×
“This can be misleading, as in one study asymptomatic PAF occurred 12 times more commonly than symptomatic PAF in patients when followed up longitudinally by Holter monitoring.(2) PAF is usually defined temporally, as intermittent periods of AF interspersed with episodes of normal sinus rhythm, normally lasting -7 days…”
BackgroundClinical Outcomes After Ablation and Pacing Therapy for Atrial Fibrillation: A Meta-Analysis
Wood, M. A., Brown-Mahoney, C., Kay, G. N., & Ellenbogen, K. A. (2000) · Circulation · doi:10.1161/01.cir.101.10.1138 · Cited by 476 · cited 2×
“The most recent meta-analysis by Wood et al.(87) of 21 studies with a total of 1181 patients with refractory atrial tachyarrhythmias (AF in 97%) reported that ‘ablate and pace’ improved quality of life, ejection fraction, exercise duration and healthcare usage, with 1-year total and sudden death mortality rates of 6.”
Background
Cited by
January, C. T., Wann, L. S., Alpert, J. S., Calkins, H., Cigarroa, J. E., Cleveland, J. C., Conti, J. B., Ellinor, P. T., Ezekowitz, M. D., Field, M. E., et al. (2014) · Circulation · doi:10.1161/cir.0000000000000041 · Cited by 7,115
Fuster, V., Rydén, L. E., Cannom, D. S., Crijns, H. J., Curtis, A. B., Ellenbogen, K. A., Halperin, J. L., Le Heuzey, J.-Y., Kay, G. N., Lowe, J. E., et al. (2006) · Circulation · doi:10.1161/circulationaha.106.177292 · Cited by 2,805
ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation: executive summary
Fuster, V., Rydén, L. E., Asinger, R. W., Cannom, D. S., Crijns, H. J., Frye, R. L., Halperin, J. L., Kay, G. N., Klein, W. W., Lévy, S., et al. (2001) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(01)01587-x · Cited by 1,348
Atrial fibrillation complicating the course of degenerative mitral regurgitation
Grigioni, F., Avierinos, J.-F., Ling, L. H., Scott, C. G., Bailey, K. R., Tajik, A. J., Frye, R. L., & Enriquez-Sarano, M. (2002) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)01922-8 · Cited by 386
Kishore, A., Vail, A., Majid, A., Dawson, J., Lees, K. R., Tyrrell, P. J., & Smith, C. J. (2014) · Stroke · doi:10.1161/strokeaha.113.003433 · Cited by 374
Metadata
- Authors
- Lip, G. Y. H.
- Venue
- QJM
- Publisher
- Oxford University Press (OUP)
- Published
- 2001-12-01
- Volume
- 94
- Issue
- 12
- Pages
- 665-678
- ISSN
- 0033-5622 (ISSN-L)
- 1460-2393
- OpenAlex
- W2045622353
- Cited by
- 145
- References
- 3
- FWCI
- 4.53
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Paroxysmal atrial fibrillation. https://app.cochat.ai/papers/10.1093/qjmed/94.12.665
- The paper
- Lip, G. Y. H. (2001). Paroxysmal atrial fibrillation. QJM. https://doi.org/10.1093/qjmed/94.12.665
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.